Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: Results of the comparison of abciximab complications with hirulog for ischemic events trial (cachet)

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Lincoff, A. M.
  • Kleiman, N. S.
  • Kottke-Marchant, K.
  • Maierson, E. S.
  • Maresh, K.
  • Wolski, K. E.
  • Topol, Eric

publication date

  • May 2002

journal

  • American Heart Journal  Journal

subject areas

  • Aged
  • Angioplasty, Balloon, Coronary
  • Antibodies, Monoclonal
  • Anticoagulants
  • Antithrombins
  • Chemotherapy, Adjuvant
  • Drug Therapy, Combination
  • Feasibility Studies
  • Female
  • Heparin, Low-Molecular-Weight
  • Hirudin Therapy
  • Hirudins
  • Humans
  • Immunoglobulin Fab Fragments
  • Male
  • Middle Aged
  • Peptide Fragments
  • Pilot Projects
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Recombinant Proteins
  • Stents
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0002-8703

Digital Object Identifier (DOI)

  • 10.1067/mhj.2002.122173

PubMed ID

  • 12040347
scroll to property group menus

Additional Document Info

start page

  • 847

end page

  • 853

volume

  • 143

issue

  • 5

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support